Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which ICU score best predicts survival? a Head-to-Head test

NCT ID NCT07780617

Knowledge-focused Sponsor: Tribhuvan University Teaching Hospital, Institute Of Medicine. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study compares three common scoring systems—SAPS II, SOFA, and APACHE II—to see which one most accurately predicts death in the intensive care unit. Researchers will follow about 200 critically ill adults admitted to a hospital ICU for at least 24 hours. The goal is to find the most reliable tool to help doctors assess severity and anticipate outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If one scoring system proves more accurate, it could help doctors better predict which ICU patients are at highest risk, potentially guiding treatment decisions.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may not apply to all ICUs, and the scores are just predictions, not guarantees.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

201 people

The number who actually took part.

Started

Jul 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Admitted to ICU

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 18 years and above Admitted to ICU with expected stay of more or equal to 24 hours Exclusion Criteria: * whose consent could not be obtained * treatment limitation order in form of DNI/DNR, withdrawal of life support

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Icu mortality are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Icu mortality

Contacts and locations

Locations

  • Bharatpur Hospital

    Bharatpur, Bagmati, Nepal